The ATP binding cassette transporter G1 (ABCG1) is a member of a large superfamily of evolutionarily conserved transmembrane proteins that transport a variety of molecules across membranes. Many of the approximately 48 known human ABC transporters, which are divided into seven families (A-G), have been implicated in disease (1, 2) . ABCG1, originally termed "White" and "ABC8" (3) (4) (5) , is a half-transporter (74-76 kDa) possessing one ATP binding/hydrolysis cassette and one transmembrane domain and is presumed to form dimers or multimers with either itself or another half-transporter to assemble a functional complex (6) . ABCG1 mRNA is expressed at high or moderate levels in macrophages, spleen, lung, thymus, placenta, brain, and fetal tissues, and at lower levels in most other tissues, including liver (3) (4) (5) (7) (8) (9) .
Recent studies have implicated ABCG1 in the cellular transport and efflux of cholesterol and possibly phospholipids. Klucken et al. (10) first demonstrated that treatment of human macrophages with antisense oligonucleotides targeting ABCG1 mRNA resulted in decreased efflux of cholesterol and phospholipids to HDL 3 , a major fraction of high density lipoprotein (HDL). More recently, Wang et al. (11) and Nakamura et al. (12) reported that increased expression of ABCG1 or the closely related transporter ABCG4 in human embryonic kidney cells increased cholesterol efflux to HDL. Other studies have shown that overexpressing ABCG1 in mouse hepatocytes via adenovirus infection reduced plasma HDL levels and increased cholesterol secretion into bile, findings consistent with a role for ABCG1 in the transport of cholesterol in liver cells (13, 14) . Furthermore, green-fluorescent proteintagged human ABCG1 protein in HeLa cells was found to be localized in endocytic compartments and the plasma membrane, consistent with a role for ABCG1 in intracellu-lar sterol trafficking as well as efflux (15) . These combined findings suggest a role for ABCG1, as yet undefined, in reverse cholesterol transport, the process whereby excess cholesterol is removed from cells, transported to the liver, and excreted into bile (16) .
As might be anticipated, ABCG1 gene expression is highly regulated by cholesterol. ABCG1 mRNA levels in cultured mouse and human macrophages were highly induced by lipid loading with acetyl low density lipoprotein (Ac-LDL) (10, 17, 18) and reduced by lipid depletion (10) . Furthermore, the normally low level of ABCG1 mRNA in rat liver parenchymal cells was increased 4-fold by feeding a high-cholesterol diet (9) . These combined data suggest sterol-mediated regulation of ABCG1 gene expression in macrophages, which are important in the initiation of atherosclerosis and, in liver, the major tissue involved in cholesterol homeostasis.
Lipid loading or a high-cholesterol diet stimulates reverse cholesterol transport through the activation of the liver X receptor (LXR) transcriptional pathway (19) (20) (21) . The LXR nuclear receptors LXR ␣ and LXR ␤ form obligate heterodimers with retinoid X receptors (RXRs) and bind naturally occurring oxidized cholesterol derivatives such as 24( S ),25-epoxycholesterol, 22( R )-, 24( S )-, and 27-hydroxycholesterol (18, (21) (22) (23) (24) and synthetic nonsteroidal compounds such as T-0901317 (25) . RXR receptors bind the agonist 9-cis -retinoic acid (9cRA) (26) . LXR/ RXR heterodimers recognize an LXR response element (LXRE) sequence containing a variant direct-repeat-4 (DR4) motif in the promoters and introns of several genes affecting lipid metabolism (22, 27, 28) . The binding of a ligand for either LXR or RXR can activate the heterodimer submaximally to stimulate transcription, whereas ligands for both receptors are required for maximal activation (29) . The LXR/RXR heterodimer is normally bound to a corepressor or coactivator protein in the absence or presence of agonists, respectively (30) (31) (32) .
LXR activation dramatically increases ABCG1 mRNA levels in macrophages (17, 33) . Venkateswaran et al. (17) demonstrated that the inducibility of ABCG1 mRNA levels by oxysterols was retained in macrophages from mice lacking either of the two LXR receptor genes but was lost in mice lacking both genes, indicating that either LXR ␣ or LXR ␤ can activate the ABCG1 gene. More recently, treatment of mice with T-0901317 has been shown to elevate markedly ABCG1 mRNA levels in several tissues, including liver, macrophages, and adipose tissue (12, 34, 35) . LXR activation also strongly activates transcription of the gene for the important cholesterol/phospholipid transporter ABCA1, which stimulates efflux to circulating apolipoprotein A-I (19, 20, 36, 37) . By the activation of the ABCA1, ABCG1, and other genes, the LXR pathway is critical to the regulation of cholesterol homeostasis, as well as the prevention of cholesterol accumulation in macrophages leading to atherosclerosis (19, 21, 33) .
The human ABCG1 gene on chromosome 21q22.3 is relatively expansive and subject to alternative RNA splicing (38) (39) (40) . The major transcript is derived from 15 exons spanning a region of 78.1 kb (38) . Its promoter region is highly GC-rich and lacks a TATA box; furthermore, the transcription start site(s) have not been adequately determined previously. Efforts to find a functional LXRE in the promoter and upstream region of the human ABCG1 gene have been unsuccessful (41) . Kennedy et al. (40) reported two putative LXREs in the second intron 2 of the human gene; however, these sequences are not conserved in the mouse and rat ABCG1 genes. Very recently, Nakamura et al. (12) published preliminary evidence for a different set of LXREs in the second intron of the mouse ABCG1 gene. Vertebrate genomes are now known to contain regions of evolutionarily conserved sequence far from exons and promoters that regulate gene transcription over large distances (42) (43) (44) . Adopting this perspective in the present study, we have employed evolutionary conservation as a criterion for identifying potentially functional and important LXREs in and near the human ABCG1 gene. We report the characterization of two novel, robustly active, and evolutionarily conserved LXREs (LXRE-A and LXRE-B) in the first and second introns 2 of the human ABCG1 gene and demonstrate their functionality in cultured macrophage and hepatic cell lines. These studies enhance our understanding of the mechanisms by which oxysterols upregulate human ABCG1 transcription in two key tissues, liver and macrophages, where changes in ABCG1 expression and cellular cholesterol efflux may markedly alter cholesterol balance and atherogenesis.
MATERIALS AND METHODS

Materials
T-0901317 (25) was purchased from Cayman Chemical Co. (Ann Arbor, MI). 22( R )-hydroxycholesterol (22-OH-cholesterol) and 9cRA were from Sigma (St. Louis, MO). Stock solutions were dissolved in 95% ethanol. Human genomic DNA and total RNA from placenta and liver were from Clontech (Palo Alto, CA).
Analyses of ABCG1 mRNA in cell lines
RAW264.7 mouse macrophage and HepG2 human hepatoma cells [American Type Culture Collection (ATCC); Manassas, VA] were maintained in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal bovine serum. For mRNA studies, cells were grown in 75 cm 2 flasks until 60-70% confluency was reached. The medium was changed to serum-free DMEM containing 1 mg/ml BSA, and the cells were treated with LXR/RXR agonist drug(s) or vehicle for 12 h. All experimental conditions were tested in triplicate flasks. Total RNA was isolated using Trizol reagent (Invitrogen; Carlsbad, CA) as instructed by the manufacturer. Ten micrograms RAW264.7 total RNA/lane were electrophoresed on a 1% agarose gel, blotted onto ZetaProbe GT mem-branes (Bio-Rad; Hercules, CA), and probed with a 32 P-labeled 252 bp DNA corresponding to bases 1,052-1,303 of the mouse ABCG1 cDNA sequence in GenBank accession NM_009593, using standard methods for Northern blotting. Radioactive bands were visualized, quantitated on a phosphorimager (model 445SI; Molecular Dynamics, Sunnyvale, CA), and normalized to intensities of cyclophilin mRNAs obtained after rehybridizing the blot with a probe for mouse cyclophilin A (Ambion; Austin, TX, #7375). ABCG1 mRNA in HepG2 cells was detected by RT-PCR of firststrand cDNA prepared from total RNA using SuperScript II reverse transcriptase (Invitrogen). The forward and reverse PCR primers were GCCACTTTCGTGGGCCCAGTGA and TCTCATC-ACCAGCTGTGTTGCA, which amplifies a 658 bp sequence within exons 14-15 (bases 1,763-2,420 in GenBank accession BC029158). Touchdown PCR reactions containing Taq polymerase and 1 l of cDNA synthesis reaction were carried out at annealing temperatures of 63 Њ C, 61 Њ C, and 59 Њ C for 5 cycles each, followed by 57 Њ C for 25 cycles. Aliquots (12.5 l) were analyzed on a 1.2% agarose gel containing 0.5 g/ml ethidium bromide and photographed in a ChemiImager 5500 (Alpha Innotech; San Leandro, CA).
Isolation and ABCG1 mRNA analysis of primary hepatocytes
Livers of 3-month-old C57Bl/6 male mice were perfused through the vena cava and common bile duct with 3-4 ml of Liver Perfusion Medium (Invitrogen/Gibco, #17701) followed by 4-8 ml of a solution containing 7.5 mg/ml collagenase Type 1 (Worthington; Lakewood, NJ, #LS004196) and 10 l/ml protease inhibitor cocktail (Sigma, #P8340) in Hanks balanced saline solution (Gibco, #14175) supplemented with 10 mM CaCl 2 /10 mM Hepes (Gibco #15630) at 37 Њ C. The liver was dispersed by mincing and trituration in a large-bore pipette, and the suspension was passed through a nylon cell strainer (100 m pore; BD-Falcon #352360, BD-Bioscience, Bedford, MA). Hepatocytes were separated from smaller liver cell types by washing with Hepatocyte Wash Medium (Gibco, #17704) followed by centrifugations at 50 g for 5 min five to six times, after which the cells were judged by light microscopy to be entirely ( Ͼ 99.5%) hepatocytes. The isolated, washed hepatocytes were plated in 6-well poly-lysine-coated plates (BD-BioCoat, #354413) at a density of 10 6 cells/well in DMEM/F12 (Gibco, #11039) supplemented with penicillin-streptomycin-glutamine and 10% fetal bovine serum. Cells were treated with 1 M T-0901317 and/or 10 M 9cRA, or solvent alone (ethanol, final 0.2%) for 16 h.
Total RNA was isolated using the Ultraspec-RNA reagent (Biotecx; Houston, TX) according to the manufacturer's instructions. For Northern blot analysis, approximately 5 g of total RNA per lane were electrophoresed and hybridized with the mouse ABCG1 cDNA probe, and subsequently with the mouse cyclophilin A probe, as described above for cell lines. The densities of the major ABCG1 mRNA band were quantitated with ChemiImager 5500 software and normalized to cyclophilin A mRNA band intensities, and independently to 18S and 28S rRNA band intensities.
Ј -rapid amplification of cDNA ends and RNase protection analyses
Transcription start sites were determined by 5 Ј -rapid amplification of cDNA ends (RACE) through use of the Smart RACE cDNA Amplification Kit (Clontech). The gene-specific primer was TGGAGTGCCTTCGGGTCGCGAAGAGGAG, which is complementary to bases 176-203 of the coding sequence of human ABCG1 in exon 2, 2 where base 1 is the A of the ATG coding for the most upstream in-phase Met. Total RNA from human placenta, spleen, thymus, and fetal brain (Clontech), as well as THP-1 cells treated with 22-OH-cholesterol and 9cRA, was used for cDNA synthesis. Touchdown PCR reactions contained Taq polymerase and a cosolvent additive PCRx Enhancer (Invitrogen, final concentration 2-2.5 ϫ ). Annealing temperatures were 68 Њ C, 66 Њ C, and 64 Њ C for 5 cycles each, followed 60 Њ C for 30 cycles. Amplification of all cDNAs tested resulted in a heterogeneous band at 370-410 bp with a sharp midpoint at 390 bp. The most robust amplification was with placental cDNA. RACE products from placental cDNA were cloned into the pCR2.1-TOPO vector (Invitrogen), and inserts from 30 clones were sequenced.
RNase protection experiments were performed using standard procedures (45) . A template for antisense RNA synthesis was prepared by amplification of DNA of the main ABCG1 promoter and 5 Ј -untranslated regions corresponding to bases Ϫ 651 to Ϫ 48 relative to the ABCG1 translation start site, using a reverse primer having a 5 Ј -terminal T7 RNA polymerase promoter sequence. 32 P-labeled antisense RNA was prepared and annealed to total RNA from untreated or 22-OH-cholesterol/9cRA-treated THP-1 macrophages. Pancreatic and T1 RNase digestions were performed under varied conditions, and protected fragments were analyzed by polyacrylamide gel electrophoresis and autoradiography. Lengths of bands consistently protected by RNA from LXR/RXR-treated cells but not by RNA from untreated cells were used to map transcription factor start sites.
Genomic sequence analyses
Repeat-masked human and mouse genomic sequences were aligned by use of the Web-based mVISTA program (http://www. gsd.lbl.gov/VISTA/) (46, 47 (54)). Multispecies genome alignments can be visualized on the UCSC Genome Browser (http://genome. ucsc.edu) (55, 56) . For other species, we used the BLAST tool to find similar sequences from raw DNA sequence trace archives at the National Center for Biotechnology Information website (http://www.ncbi.nlm.nih.gov/blast/index.shtml).
Construction of reporter plasmids
Plasmid reporter constructs containing the ABCG1 5 Ј -untranslated region, the major promoter ["promoter B" (39) ], and varied amounts of upstream region were prepared by insertion of a nested set of genomic sequences into the Kpn I and Nhe I sites of the promotorless pGL3-Basic vector (Promega; Madison, WI). The genomic sequences were amplified from human genomic DNA. Forward primers consisted of Kpn I site-tagged sequences at varied upstream sites of the sense (coding) strand of the ABCG1 gene. The common reverse primer (GAGAAAGCGGCCATCA-GACAGCTAGCGCCC) contained the antisense strand sequence corresponding to bases Ϫ 4 to ϩ 26 (numbered relative to the A of the initiating ATG defined as 1), except for the substitution of a Nhe I site for the bases coding for the initiating Met and the secat PENN STATE UNIVERSITY, on February 28, 2013 www.jlr.org Downloaded from ond amino acid Ala. PCR reactions contained Pfx polymerase and 2.5 ϫ PCRx Enhancer (both from Life Technologies/Invitrogen) and standard components. Amplified DNA was digested with Kpn I and Nhe I and ligated into pGL3-Basic. The resulting plasmids possess the ABCG1 regulatory promoter and 5 Ј -untranslated sequences in the sense orientation placed just upstream from the reporter firefly luciferase coding sequence. These constructs were named pGL3-hABCG1( Ϫ x/ ϩ 123), where bases Ϫ x and ϩ 123 are the most upstream and downstream bases, respectively, of the insert, numbered in relation to the main ABCG1 transcription start site determined by us by 5 Ј -RACE, which is 123 bases upstream from the ATG translation initiation start site (Fig. 2) .
Intronic DNA sequences were tested for LXR responsiveness by cloning them into the Sal I site downstream of the firefly luciferase gene of the plasmid pGL3-hABCG1( Ϫ 1,013/ ϩ 123), whose preparation is described above. Some test sequences were also cloned into the Kpn I site of pGL3-hABCG1( Ϫ 1,013/ ϩ 123) just upstream from the regulatory promoter. The extended 287 bp LXRE-A region (chr21:42,513,461-42,513,747) with Sal I or Kpn I ends was obtained by PCR amplification of human genomic DNA. A clone containing base substitutions in the DR4 sequence of the LXRE-A region (1-287) were created by the use of the Quik-Change II Site-Directed Mutagenesis Kit (Stratagene; La Jolla, CA) essentially according to the manufacturer's protocol; the mutated DR4 sequence was AGGTAACTGTCtGatc, where mutated bases are shown in lowercase type. Inserts of mutant clones were sequenced, and an insert having the desired sequence was recloned into unamplified Sal I-cut pGL3-hABCG1( Ϫ 1,013/ ϩ 123), to eliminate any PCR misincorporations within the vector. The LXRE-B region (47 bp, chr21:42,528,054-42,528,100) and human LXRE-C region (47 bp, chr21:42,521,372-42,521,418) with Sal I or Kpn I ends and with or without mutations in the DR4 sequence were prepared as synthetic complementary oligodeoxynucleotides and cloned. The mutated LXRE-B and LXRE-C DR4 sequences were GcGaTtCTACCtGagA and AGGTTACTGTAtGatc, respectively, where mutated bases are shown in lowercase type. Unless otherwise indicated, clones selected for transfection studies possessed tested sequences oriented so that the strand appearing in the UCSC Genome Browser as the "upper strand" (the sense strand of human ABCG1 exons) was placed on the strand having the sense sequence of the luciferase gene. The tested 48 bp mouse LXRE-C region (chr17:29,673,084-29,673,131, May 2004 mouse genome assembly) corresponded in sequence alignment to the tested 47 bp human LXRE-C region and was cloned into the Sal I site as an oligodeoxynucleotide duplex. Clones having either one copy or two tandem copies of the mouse LXRE-C region, all in the "reverse" orientation to that defined above, were isolated and tested.
Clones possessing truncated portions of the LXRE-A region were generally prepared by PCR amplification of selected regions with primers containing Sal I sites, followed by ligation into the Sal I site of pGL3-hABCG1( Ϫ 1,013/ ϩ 123). Exceptions were the 52 bp fragments from base 79 to base 131, which were prepared by annealing of complementary oligodeoxynucleotides with protruding Sal I ends.
The sequences of the inserts were confirmed by DNA sequencing. All plasmids used in transfections were purified by use of the Endo-Free Plasmid Maxi Kit (Qiagen; Valencia, CA) or by two cycles of CsCl-ethidium chloride density gradient centrifugation.
Transfections and luciferase analyses
RAW264.7 cells (3-5 ϫ 10 5 /well) or human HepG2 cells (2 ϫ 10 5 /well) were plated in 12-well dishes containing 1 ml medium/ well, unless otherwise indicated. All experimental conditions were tested in quadruplicate wells. On the day after plating cells, each well received a solution (100 l) containing 1 g test plasmid with the firefly luciferase reporter gene, 0.050 g pRL-SV40 DNA (Promega) with the Renilla luciferase reporter gene to control for variations in transfection efficiency and cell number, 3 l Fugene 6 reagent (Roche, Indianapolis, IN), and PBS. Approximately 24 h later, the cells were washed twice with PBS, and the medium was changed to serum-free DMEM containing 1 mg/ml BSA. LXR and RXR agonist compounds in ethanol were added as indicated (final ethanol concentration 0.2%). After 24 h, cells were washed twice with PBS, lysed in Passive Lysis Buffer (Promega) supplemented with Protease Inhibitor Cocktail (Sigma), and assayed by the Dual Luciferase Assay kit (Promega) in a MicroLumat Plus LB 96V luminometer (Berthold USA; Oak Ridge, TN) according to the kit manual (2-5 l and 20 l lysate/test for HepG2 and RAW264.7 lysates, respectively). The average expression level of the Renilla luciferase in transfected cells was not consistently affected by LXR and RXR agonists. Results were expressed as the ratio of firefly to Renilla light units multiplied by 10 for convenience (mean Ϯ SEM, n ϭ 4). Statistical significance was determined by use of the unpaired two-tailed Student's t -test.
Construction and expression of plasmids encoding LXR and RXR proteins
Plasmids containing the complete coding sequences for human LXR ␣ (22), LXR ␤ (57), and RXR ␣ (58) under the control of T7 and CMV promoters were constructed in the vector pcDNA3.1 (Invitrogen). RefSeq sequences (GenBank NM_005693, NM_007121, and NM_002957, respectively) were used to design PCR primers to amplify full-length coding sequences and insert a NotI site and consensus Kozak sequence (CCACC) immediately upstream from the ATG translation start site and to insert a second stop codon (TAA) and XbaI site immediately after the native stop codon. RT-PCR was performed with Pfu Ultra HF polymerase (Stratagene), PCRx Enhancer (final concentration 2ϫ; Invitrogen), and cDNA from fetal human liver (for LXR␣ and RXR␣) and placenta (for LXR␤). Amplicons were digested with NotI and XbaI and ligated into pcDNA3.1. Clone inserts were completely sequenced in both strands. Insert sequences of all clones containing LXR␣ cDNA differed from the RefSeq sequence at three bases but agreed at these positions with the reference human genome sequence and with other human LXR␣ cDNA sequences in GenBank. Insert sequences for LXR␤ and RXR␣ cDNA were in complete agreement with the RefSeq sequences. The plasmids (termed "pcDNA-LXR␣," "pcDNA-LXR␤," and "pcDNA-RXR␣") were used as templates for LXR and RXR protein synthesis in the TNT T7 Quick Coupled Transcription/ Translation kit (Promega) according to the manufacturer's instructions; template-minus reactions were also prepared.
Electrophoretic mobility shift assays
Double-stranded 28 bp oligodeoxynucleotide probes containing the following DR4 sequences (with direct repeats in bold face) were prepared by annealing complementary single-stranded oligodeoxynucleotides and were end-labeled with [␥-32 P]ATP (3,000 Ci/mmol; Perkin-Elmer, Boston, MA) and T4 polynucleotide kinase (Invitrogen) and purified on G-25 spin columns:
LXRE-A-wt: GGCAAGAGGTAACTGTCGGTCAAATCCT LXRE-A-mut: GGCAAGAGGTAACTGTCtGatcAATCCT LXRE-B-wt: GCGCCGGGGTTACTACCGGTCAACGCTC LXRE-B-mut: GCGCCGGcGaTtCTACCtGagAACGCTC hLXRE-C-wt: CACACAAGGTTACTGTAGGGCAAGTCTC mLXRE-C-wt: CTACAGAGGTTACTACAGGGCAAACAGC LXRE-A-50: CTCTTGAGCTCAAGGCAAGAGGTAACTGTCG-GTCAAATCCTGCTGAGCCC LXRE-A-50-centro: GGCAAGAGGTAACTGTCGGTCAAATC-CTGCTGAGCCCTGCTGACTTCAAA LXRE-A-50-telo: TTTTTTTTCTCTTGAGCTCAAGGCAAGAG-GTAACTGTCGGTCAAATCCTT at PENN STATE UNIVERSITY, on February 28, 2013 www.jlr.org
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Gel shift binding reaction mixtures (10 l final volume) contained (as indicated in figure legends) either 0.5-1 l cell-free transcription/translation reaction mixture for each receptor tested or 1 g RAW264.7 cell nuclear extract (59) (Paragon Bioservices; Baltimore, MD), as well as 20 mM Tris HCl (pH 7.9), 60 mM KCl, 1.3 mM MgCl 2 , 0.2 mM EDTA, 0.5 mM dithiothreitol, 10% glycerol, 3% Ficoll, 50 g/ml poly dI:poly dC, and 20,000 cpm 32 P-labeled probe (2,500-5,000 cpm/fmol, added last). Incubations were for 10 min at room temperature followed by an additional 10 min on ice. For competition assays, unlabeled double-stranded probe in molar excess over the labeled probe was added and incubated with the receptors and buffer for 3 min prior to addition of the probe. In supershift assays, 4 g immunoglobulin G (IgG) antibodies (Santa Cruz Biotechnology; Santa Cruz, CA) were preincubated for 10 min at room temperature with reaction mixtures prior to addition of the probe. The samples were loaded onto 6% polyacrylamide nondenaturing gels containing 0.5 ϫ Tris-borate-EDTA (TBE) buffer (Invitrogen) and electrophoresed at 100 V for 30 min followed by 130 V for 1.5 h. The gels were dried and analyzed by a phosphorimager.
Chromatin immunoprecipitation (ChIP) assay
THP-1 human monocyte cells (ATCC) were maintained in RPMI-1640 medium with 10% fetal bovine serum and were differentiated by treatment with 50 nM phorbol myristate acetate (PMA) for 48-72 h. The medium was changed to serum-free RPMI-1640 with 1% BSA, and cultures were treated with 1 M T-0901317 plus 5 M 9cRA, or solvent (ethanol) alone, for 90-120 min. The ChIP-IT kit (Active Motif; Carlsbad, CA) and accompanying protocol were used for subsequent steps. Briefly, the cells were fixed with 1% formaldehyde for 10 min at room temperature. Nuclei were isolated and sonicated on ice to shear the chromatin to fragments of 200-1,200 bp (average 500 bp). ChIP reactions (4ЊC, overnight) contained precleared unfrozen chromatin (50 g protein or 8 g DNA from 1.2-1.5 ϫ 10 6 cells) and 3 g of rabbit IgG. Protein G-agarose beads (100 l, preblocked additionally with 1 mg/ml sonicated herring sperm DNA) were added, and the beads were subsequently washed extensively. Bound chromatin was eluted with 1% SDS at 60ЊC for 10 min and purified on spin columns supplied with the kit.
The recovered DNA was assayed for sequences closely surrounding LXRE DR4 motifs by PCR reactions (25 l) containing 3 l ChIP DNA (or 3-5 ng DNA isolated from each chromatin preparation), Platinum Taq polymerase (Invitrogen), and the following pairs of forward and reverse primers to amplify sequences of indicated lengths: LXRE-A, CCGAGGCTGTAAGCCCACAGT, GCGGAGCATGCGCAGAAACCT, 183 bp; LXRE-B, CTCAACGC-CCGGGAGAAAACAG, CTCCGCCGCGGAGGTTACTA, 164 bp; LXRE-C, AGTGAGGGAGGAGCCCCAACT, ACCCCTCTGGCT-CCACCCATTT, 170 bp. The PCR program consisted of 32-34 cycles of 94ЊC for 25 s, 58ЊC for 30 s, and 72ЊC for 30 s. Reactions for amplification of the LXRE-B sequence required cosolvent (1.75ϫ PCRx Enhancer; Invitrogen) because of its high GC content. Amplification products were electrophoresed on a 2.5% agarose gel containing 0.25% ethidium bromide and photographed.
RESULTS
LXR and RXR agonists upregulate ABCG1 gene expression in cultured macrophages, hepatoma cells, and primary hepatocytes
We evaluated potential LXREs using two well-differentiated cell lines, RAW264.7 mouse macrophage cells and HepG2 human hepatoma cells, which serve as model systems, with limitations, for normal macrophages and hepatic parenchymal cells (hepatocytes), respectively. Prior to transfection, we demonstrated that the endogenous ABCG1 gene in these cells and in primary mouse hepatocytes is responsive to LXR agonists. In RAW264.7 cells, we found by Northern blot analysis (Fig. 1A) that treatment with T-0901317 or 9cRA for 12 h increased the relative abundance of 3.8 kb full-length mature ABCG1 mRNA to 6.5 Ϯ 0.7ϫ and 3.4 Ϯ 0.5ϫ control, respectively, whereas treatment with both drugs increased the abundance to 8.1 Ϯ 1.5ϫ control (means Ϯ SEM, n ϭ 3, normalized to cyclophilin mRNA levels). In untreated and treated HepG2 cells, we could not detect ABCG1 mRNA by Northern analysis (data not shown). Nevertheless, as illustrated in Fig. 1B , we were able to consistently amplify ABCG1 cDNA prepared from RNA from HepG2 cells treated with T-0901317 Ϯ 9cRA but not from cells treated with solvent alone, indicating that the levels of ABCG1 mRNA in HepG2 cells, although extremely low, are upregulated by LXR agonist. Our overall results are consistent with previous reports demonstrating induction of ABCG1 mRNA by oxysterols and 9cRA in RAW264.7 cells (17) and by oxysterols in HepG2 cells (60) .
To further investigate the physiological relevance of the HepG2 findings with respect to the liver, we studied the induction of ABCG1 mRNA by T-0901317 and/or 9cRA in isolated primary mouse hepatocytes (Fig. 1C) . By Northern analysis, a faint band at 3.8 kb consistent with mature full-length ABCG1 mRNA was detected in RNA from primary hepatocytes treated with solvent alone. Treatment of the cells with T-0901317 or 9cRA for 16 h increased its relative abundance to 6.1ϫ and 1.6ϫ control, respectively, whereas treatment with both drugs elicited an increase to 8.5ϫ control (normalized to cyclophilin mRNA levels). These results demonstrate that ABCG1 mRNA in isolated primary hepatocytes, although normally low in abundance, is detectable and strongly upregulated by LXR agonist, with additional potentiation by RXR activation.
Identification of major transcription start sites
Previous attempts to identify the transcription start site(s) associated with the major human ABCG1 promoter [termed "promoter B" (39) ] utilizing the 5Ј-RACE method were unsuccessful because of difficulty in amplifying the 5Ј-untranslated region, which contains a 49 bp GC-rich region including a (CCG) 10 repeat (38, 39) . We used the independent methods of 5Ј-RACE, with an additive to destabilize GC-rich templates, and RNase protection. By the 5Ј-RACE method, we identified several apparent start sites, the major one of which was at base Ϫ123 relative to the first in-phase ATG translation start site (Fig. 2) . More-distant but less-utilized start sites were found at bases Ϫ130, Ϫ140, and Ϫ146. By the RNase protection method, we found multiple bands of antisense RNA protected from digestion by annealing with RNA from LXR/RXR-agonisttreated THP-1 human macrophage cells (gel not shown). Most bands were in a cluster corresponding to start sites at base Ϫ116 to Ϫ121 relative to the translation start site (ac-
concordant results, we conclude that the major promoter of the ABCG1 gene possesses multiple transcription start sites, the most upstream site at base Ϫ146 and the most common site at or around base Ϫ123, relative to translation initiation. These sites are 40 and 17 bases, respectively, farther upstream than the most upstream 5Ј end of the major human ABCG1 mRNA transcript reported to date [GenBank accession BC029158, from Mammalian Gene Collection (61)]. The major start site found by us (Ϫ123) is consistent with that found by others for the mouse ABCG1 gene (12, 39) , according to an alignment (UCSC Genome Browser) of the loosely conserved human and mouse sequences. We refer hereafter to the predominant start site as base ϩ1 of exon 1; 2 the first base of the translation initiation codon would then be ϩ124.
Identification of evolutionarily conserved putative LXREs
To identify sequences responsible for the marked responsiveness of the ABCG1 gene to oxysterols, we searched for putative LXREs that are evolutionarily conserved in human and mouse genomic sequences using the MatInspector and rVISTA programs, which employed nonidentical matrices and core definitions. Our search covered a 155,953-base region of the finished human chromosome 21 sequence (62), including 64,971 bases upstream from the major translation start site, all reported exons and introns of the ABCG1 gene, and 13,003 bases downstream from the last exon, as well as corresponding sequences near and within the mouse ABCG1 gene on chromosome 17 (51) . We found two highly conserved putative LXREs that scored highly in both programs and a third that scored highly in only one program (Fig. 3A) .
The first candidate LXRE, termed "LXRE-A" (Fig. 3B) , is located in the first intron. 2 Its DR4 motif (MatInspector and rVISTA core/matrix scores 1.000/0.943 and 0.937/ 0.908, respectively) is located 1,247 bp downstream from the major transcription start site and in a region of ‫082ف‬ bp of sequence that is evolutionarily highly conserved in ABCG1 genes of mammals and, to a lesser extent, chicken. The DR4 bases are nearly identical in the first intron of the human, dog, mouse, and chicken ABCG1 genes (Fig.  3B) , as well as in the ABCG1 orthologs of chimpanzee, cow, and laboratory opossum (Monodelphis domestica) (not shown). Potentially orthologous conserved sequences are found also in publicly available unassembled raw sequences of the genomes of rat, elephant, nine-banded armadillo (Dasypus novemcinctus), and duck-billed platypus (Ornithorhynchus anatinus) (not shown).
The second candidate LXRE, termed "LXRE-B" (Fig.  3C) , is in the second intron, 14,500 bp downstream from the main transcription start site, in a small region ‫74ف(‬ bp) of very high human/mouse conservation within a broader region ‫081ف(‬ bp) of moderately conserved sequence. The DR4 motif (MatInspector and rVISTA scores l.000/0.964 and 1.000/0.981, respectively) is highly conserved, except for the third and fourth inter-repeat bases, in the second intron of the human, chimpanzee, dog, mouse, rat, chicken, and opossum ABCG1 orthologs. Surprisingly, it is also conserved in the compact second intron of a potentially orthologous ABCG1-like gene of the pufferfish T. nigroviridis.
A third candidate LXRE, termed "LXRE-C" (Fig. 3D) , was found in a broad region of moderate sequence conservation in the second intron at 7,814 bp from the main transcription start site. It scored highly (1.000/0.886) in the rVISTA program but low (0.727/0.871) in the MatInspector program. Its DR4 sequence is conserved in the second intron of the human, chimpanzee, dog, mouse, rat, and cow ABCG1 genes; however, neighboring sequences on either side are less well conserved. In the chicken gene, the overall LXRE-C region appears to be less well conserved.
LXRE-A, -B, and -C differ from those previously reported for the human ABCG1 gene and located in the distal part of the second intron (40) . The latter sequences are not conserved in rodent genomes and have lower MatInspector scores than those of LXRE-A and LXRE-B. In contrast, the mouse orthologs of LXRE-B and -C have recently been reported to confer LXR/RXR responsiveness to transfected test plasmids (12) .
Lack of an LXRE in the promoter/upstream region
We tested the promoter/upstream region for a functional LXRE by transfecting into RAW264.7 cells plasmid constructs containing up to 4,793 bp of DNA upstream from the major transcription start site. As shown in Fig. 4 , promoter/upstream sequences of 1,013 and 4,793 bp in length (constructs B, C) drove moderately strong expression of the reporter gene, compared with the promoterless pGL3-Basic vector (construct A) but did not confer responsiveness to T-0901317, as expected from our sequence analyses. Similar results were obtained with constructs containing between 244 and 2,033 bp of promoter/upstream sequence (data not shown). The construct with 1,013 bp of promoter sequence [pGL3-hABCG1(Ϫ1,013/ϩ123), construct C] was subsequently used as a vector to assay the functionality of intronic sequences.
LXRE-A and LXRE-B are responsive to LXR agonist alone
To determine whether the LXRE-A, -B, and -C sequences are functionally active, we ligated segments of conserved sequences (287, 47, and 47 bp, respectively, termed "LXRE regions") containing the DR4 motifs and potentially important neighboring sequences into a site downstream (or in some cases upstream) from the reporter gene in pGL3-hABCG1(Ϫ1,013/ϩ123) (Fig. 4, construct C) . To perform this initial screen, mouse RAW264.7 macrophage cells were transfected with the individual constructs and subsequently treated with T-0901317.
The presence of the LXRE-A region, placed either downstream from the reporter gene or immediately upstream from the promoter, conferred strong responsiveness to T-0901317 (Fig. 4, constructs D-G) . The degree of stimulation (3-to 5-fold) was independent of the position and orientation of the LXRE-A region relative to the promoter. Site-directed mutagenesis of the DR4 motif abolished the responsiveness of the LXRE-A region to T-0901317 (from 5-to 0.8-fold stimulation, construct H). Similar plasmid constructs containing the LXRE-B region downstream from the reporter gene in either orientation were highly responsive to LXR agonist treatment (Fig 4, constructs I , J). The 6-to 8-fold activation by LXRE-B was consistently higher than that by LXRE-A (comparing constructs I, J and D-G). Mutation of critical bases in the DR4 motif of the LXRE-B region in both the forward (construct K) and reverse (data not shown) orientations abolished the LXR responsiveness of these plasmid constructs. In contrast, a similar plasmid construct containing the LXRE-C region instead of LXRE-A or -B placed downstream from the reporter gene conferred little or no responsiveness to LXR agonist (construct L).
LXRE-A and LXRE-B are responsive to stimulation by LXR and/or RXR agonists in macrophage and hepatoma cells
In transfected RAW264.7 macrophage cells (Fig. 5A) , the ABCG1 promoter in the absence of an LXRE was not stimulated by the LXR agonists 22-OH-cholesterol or T-0901317 alone, whereas the RXR agonist 9cRA, alone or in combi- A similar stimulation by 9cRA, however, was also observed in the promoterless pGL3-Basic vector (inset), indicating that the 9cRA stimulation of constructs lacking an LXRE is due to cryptic element(s) in the basic vector, rather than to the ABCG1 promoter. The LXRE-A region conferred the ability of LXR agonists and 9cRA separately to activate the ABCG1 promoter approximately 3-fold and 6-fold, respectively, and in combination, to synergistically activate it 16-to 18-fold (second bar cluster). The LXRE-A region mutated in the DR4 motif was unresponsive to LXR agonists with or without 9cRA (third bar cluster). The wildtype but not mutated LXRE-B region also conferred strong LXR responsiveness, but in a pattern different from that of LXRE-A and characterized by a stronger response to LXR agonist alone (6-to 8-fold) and a smaller, less than additive, enhancement by 9cRA, to achieve a maximum activation of 10-to 11.5-fold (fourth and fifth bar clusters).
We obtained similar but slightly divergent results with transfected HepG2 hepatoma cells (Fig. 5B) . The intrinsic activity of the human ABCG1 promoter was consistently higher in HepG2 cells than in RAW264.7 cells. In HepG2 cells, the LXRE-A region conferred the ability of T-0901317 and 9cRA separately to activate the ABCG1 promoter 4.2-fold and 5.2-fold, respectively, and in combination, synergistically to activate it 18-fold (Fig. 5B, second bar cluster) . Mutation of the DR4 of the LXRE-A region abolished responsiveness to LXR agonist with or without 9cRA (third bar cluster). In HepG2 cells, unlike in RAW264.7 cells, the presence of the wild-type LXRE-B region enhanced promoter activity approximately 3-fold in the absence of an added LXR agonist (fourth bar cluster). However, the addition of T-0901317 or 9cRA alone increased activity further by factors of 4.3 and 2.0, respectively. Mutations in the DR4 of the LXRE-B region led to a virtual loss of responsiveness to the LXR and RXR agonists (fifth bar cluster).
The activities of human and mouse LXRE-C were similarly tested in transfection experiments with RAW264.7 cells (Fig.   5C ) and HepG2 cells (data not shown). Human LXRE-C was unresponsive to LXR agonist in the presence or absence of RXR agonist (Fig. 5C, third bar cluster) , compared with the LXRE-A region tested in the same experiment (second bar cluster, 3.4-to 4.3-fold and 11-fold stimulation by LXR and LXR/RXR agonists, respectively). However, plasmids containing one copy of the mouse LXRE-C region were moderately responsive (fourth bar cluster, 1.8-to 3.0-fold and 4.0-to 5.1-fold stimulation by LXR and LXR/RXR agonists, respectively), and plasmids containing two tandem copies of the mouse LXRE-C region were highly responsive (fifth bar cluster, 11-to 14-fold and 33-to 35-fold stimulation by LXR and LXR/RXR agonists, respectively).
In conclusion, the human LXRE-A region and the human LXRE-B region confer robust responsiveness to LXR/ RXR agonists. The LXRE-A region mediates a moderate response to LXR agonist alone and a very strong and syn- ergistic response to combined LXR ϩ RXR agonists, whereas the LXRE-B region mediates a stronger response to LXR agonist alone, a response which is enhanced modestly, if at all, by the addition of RXR agonist. Although the human LXRE-C region appears to be essentially inactive, the mouse LXRE-C region is active.
Candidate LXREs are recognized by overexpressed LXR/RXR in cultured macrophage and hepatic cells
To further test whether LXR and RXR receptors recognize the candidate LXREs in cells, we measured responsiveness of the constructs containing LXRE regions when cotransfected with plasmids expressing LXR (␣ or ␤) and (Fig. 6) . Basal and LXR/RXR agonist-stimulated luciferase expression from plasmid constructs containing the LXRE-A region or the LXRE-B region was very strongly enhanced by cotransfected LXR␣/RXR␣ and, to a lesser extent, LXR␤/RXR␣ in HepG2 cells (Fig. 6 , first three clusters of bars). The maximal overall activity of the promoter was achieved with the LXRE-A region in the presence of overexpressed LXR␣/RXR␣, whereas the maximal activity with the LXRE-B region and overexpressed LXR␣/RXR␣ was approximately 60% of that with the LXRE-A region. Similar results were obtained with transfected RAW264.7 cells (data not shown). These results demonstrate that the human ABCG1 promoter is capable of very high activity when stimulated maximally by the LXR system acting through the LXRE sequences of this gene.
In contrast to its ineffectiveness in cells containing endogenous levels of receptors, the human LXRE-C region also conferred robust responsiveness to LXR agonist in the presence of cotransfected LXR/RXR, although to a lesser degree than that mediated by LXRE-A and LXRE-B (Fig. 6, fourth cluster of bars) . These findings indicate that the LXRE-C region is capable of conferring some, albeit relatively weak, LXRE responsiveness when LXR/ RXR receptor concentrations are high enough to activate transcription through suboptimal LXRE sequences.
Responsiveness of LXRE-A requires sequences neighboring the DR4 motif
Plasmid constructs containing the LXRE-A DR4 with few surrounding bases were found to be much less responsive to LXR agonist than was the well-conserved 287 bp LXRE-A region. To analyze the requirement for sequences neighboring the DR4, we prepared and tested a series of constructs that lack various segments of the 287 bp LXRE-A region, in which the DR4 motif is found at bases 106-121. As shown in Fig. 7 , deletion of bases 128-287 (retaining 1-127) reduced responsiveness dramatically (from 13.5-to 2.0-fold). Removal of bases 1-75 alone (retaining 76-287) did not affect responsiveness. The highly truncated DR4-containing sequence 79-131 conferred only 1.8-fold stimulation by LXR/RXR agonists, and this response was further blunted when the DR4 motif was mutated. Some contribution of bases 235-287 to the maximal responsiveness was also found. We conclude that the overall LXRE-A region is a complex regulatory locus in which multiple regions are required for maximal LXR responsiveness. These regions contain several domains of high 
LXRE-A and LXRE-B bind LXR and RXR in vitro and in vivo
To demonstrate that the DR4 elements of human LXRE-A and LXRE-B bind LXR/RXR heterodimers in cell-free systems, we performed electrophoretic mobility shift (gel shift) assays (EMSAs) with cell-free translated recombinant LXR and RXR proteins and short (28 bp) LXRE 32 P-labeled double-stranded probes. As shown in Fig. 8A , LXR␣, LXR␤, or RXR␣ alone did not bind to either probe, while the combinations LXR␣/RXR␣ and LXR␤/RXR␣ bound well to both. Thus the LXRE-A and LXRE-B sequences display the expected structural requirements for the heterodimerized receptors to form a stable complex. No strong preference of one paralog of LXR receptor for a particular LXRE was found. As expected, binding of LXR/RXR to 32 P-labeled LXRE-A and LXRE-B probes (28 bp) having mutated DR4 motifs was negligible compared with the wild-type probes (data not shown). Recombinant LXR␣/RXR␣ and LXR␤/RXR␣ heterodimers also similarly bound 32 P-labeled 28 bp duplexes containing either the human or mouse LXRE-C motifs (data not shown).
The binding of cell-free translated LXR␣/RXR␣ and LXR␤/RXR␣ heterodimers to LXRE-A and -B probes was blocked by a 30-fold (Fig. 8B) or 10-fold (data not shown) molar excess of nonradioactive oligonucleotide duplexes having either the same sequence as the probe or the sequence of the other LXRE. These results demonstrate that the LXRE-A and LXRE-B sequences bind to the same DNA binding site on the LXR/RXR heterodimers in this assay. In contrast, a 30-fold molar excess of LXRE-A or LXRE-B duplexes having sequences mutated in the same bases that were mutated for our transfection studies (Figs. 4, 5) failed to compete with the labeled LXRE-A or LXRE-B probes.
To perform chromatin immunoprecipitation experiments, we required an LXR antibody that can supershift natural LXR/RXR corepressor/coactivator complexes, in which epitope availability may differ from that in the cellfree translated LXR/RXR heterodimer. A screen of commercially available LXR antibodies using the gel shift assay revealed only one antibody that could supershift RAW264.7 nuclear protein complexes with short (28 bp) probes having LXRE-B and -C sequences (Fig. 9A, lanes 3-8, bands b and s) or the sequence of the known LXRE in the promoter of the human ABCA1 gene (36, 37) (data not shown). In contrast to LXRE-B and -C, a 28 bp LXRE-A probe bound to a faster migrating and nonsupershifted complex (lanes 1-2, band a) . However a longer 50 bp LXRE-A probe (LXRE-A-50-centro) containing 28 bp upstream from the at PENN STATE UNIVERSITY, on February 28, 2013 www.jlr.org Downloaded from DR4 motif was able to form a more slowly migrating and supershiftable complex (lanes 11-12, bands bЈ and s), indicating that the LXRE-A sequence, unlike the LXRE-B and -C sequences, requires bases farther from the DR4 core to bind the natural receptor complex in the EMSA. Similar results were obtained with THP-1 nuclear extracts (not shown).
Chromatin immunoprecipitation assays were performed to determine whether LXR and RXR are bound to the tested LXRE regions in nuclei of cells in which the ABCG1 gene is undergoing LXR-dependent transcriptional activation. For these studies, we used human THP-1 macrophage cells, in which ABCG1 mRNA is strongly and rapidly induced by treatment with LXR and RXR agonists in combination (39, 40) (unpublished observations). As shown in Fig. 9B , LXRE-A, -B, and -C-containing chromatin fragments from agonist-treated THP-1 cells were enriched by immunoprecipitation with anti-LXR (the same antibody that elicited supershifts shown in Fig. 9A ) and anti-RXR. These results provide qualitative evidence that in living macrophage cells, LXR and RXR bind to the LXRE-A, -B, and -C sequences of the ABCG1 gene. 
DISCUSSION
The ABCG1 transporter is expressed in multiple tissues in which cholesterol transport and metabolism take place, including macrophages, liver, adipose tissue, and brain. In view of the potential role of ABCG1 in cholesterol trafficking and efflux (10) (11) (12) (13) (14) (15) , the identification of regulatory elements that modulate ABCG1 gene expression is important. The ABCG1 gene is noteworthy for its strong inducibility by LXR agonists such as hydroxycholesterols and T-0901317 and by lipid loading of cells by Ac-LDL, which activates the LXR system. The likelihood of an important function for ABCG1 in macrophages, where its gene is highly expressed, has been well appreciated, but ABCG1 may also play an important role in hepatocytes, where its mRNA levels can be strongly upregulated through the LXR system to levels that are likely to be functionally significant (Fig. 1C) . Consistent with this proposal, Hoekstra et al. (9) reported that in rats, a high-cholesterol diet increased the ABCG1 mRNA abundance in hepatocytes 4-fold; because of the substantially greater abundance of hepatocytes relative to macrophages in liver, the contribution of these cells to total hepatic ABCG1 message was estimated to rise from 25% to 60%. Our findings provide a mechanistic explanation for this observation and suggest a potentially important role of hepatocyte ABCG1 in regulating cholesterol homeostasis.
Previous reports of LXREs in the mammalian ABCG1 gene have presented a confusing picture because of nonidentity of the proposed human and mouse LXREs and limitations of the string-search method used to detect them (12, 40) . In this study, we performed an extensive search for LXREs around and within the ABCG1 gene, taking note of previous reports of functional LXREs in introns of other genes (63, 64) and utilizing evolutionary conservation to assess potential functional importance of candidate sequences. We have identified two potential LXREs in the first two introns of the mammalian ABCG1 gene that are likely to be important loci of LXR regulation by virtue of satisfying three criteria: i) robust activity in cultured cells transfected with reporter plasmid constructs driven by the physiologically relevant ABCG1 promoter; ii) binding to LXR/RXR homodimers dependent on critical nucleotides in the DR4 motifs; and iii) evolutionary conservation in not only human and mouse, where LXR regulation of ABCG1 has been demonstrated (17) , but also in other mammals and in chicken.
The two elements that we identified and characterized, LXRE-A and LXRE-B, are similar in that both confer strong LXR-agonist inducibility of the reporter gene when present on plasmid constructs in single copies and in the presence of endogenous levels of LXR and RXR in RAW264.7 and HepG2 cells (Figs. 4-6 ). However, LXRE-A and LXRE-B appear to differ in several respects. The first difference is that although the DR4 sequence of LXRE-B fits precisely a consensus sequence (rRGGTYActnnMGKTCA) of many LXREs, the DR4 of LXRE-A has an unusual A in base 5 of the first repeat. The second difference is in the reporter-gene responses to added LXR and RXR agonists. With LXRE-A, each type of agonist elicited significant but modest responses alone and a synergistically strong response when added together, whereas LXRE-B conferred a strong responsiveness to LXR agonist alone that was not strongly affected by added RXR agonist (Fig. 5) . The third difference is that LXRE-A requires a larger expanse of neighboring bases than does LXRE-B for conferring robust LXR activation to the ABCG1 promoter (Fig. 7) . This finding suggests that LXRE-A resides within an enhancer region more complex than that containing LXRE-B. Although the DR4 elements with only a few neighboring bases bind LXR/RXR heterodimers well in cell-free systems (Fig. 8A, B) , sequences farther away are apparently required for proper binding of the LXREs to receptor-corepressor and -coactivator complexes (30, 32) and for the assembly of chromatin remodeling complexes.
The relative importance of the two LXREs in regulating the ABCG1 gene cannot be ascertained at present. On the one hand, LXRE-A may be more significant because its distance from the ABCG1 transcription start site (1,247 bp) is much less than that of LXRE-B (14,500 bp), and the maximal stimulation by LXR/RXR agonists is greater than that by LXRE-B in the cell lines tested (Figs. 5, 6 ). On the other hand, LXRE-B appears to be conserved over a greater evolutionary period than LXRE-A, and its greater distance from the ABCG1 promoter should not be prohibitively long (44) . Probably both LXREs contribute, perhaps cooperatively, to the response of the endogenous gene.
LXRE-A and LXRE-B may also regulate the transcription of alternate human ABCG1 transcripts. Lorkowski et al. (39) identified transcripts in THP-1 monocytes that were initiated at a promoter ("promoter A") 19.3 kb upstream from the originally described promoter analyzed in this study ("promoter B"). Transcripts from both promoters were found to be strongly induced in THP-1 cells by treatment with LXR/RXR agonists, although the relative promoter usage was not determined. We confirmed these findings with both THP-1 and human spleen RNA using semiquantitative RT-PCR and found that promoter A usage is much less than promoter B usage in both tissues (data not shown). Because MatInspector analyses detected no high-scoring putative LXRE in the nonrepetitive sequence of a broad region around promoter A, we conclude that promoter A may be regulated through the same LXREs as those regulating promoter B.
After we completed most of our studies on human LXREs, Nakamura et al. (12) reported the identification of two LXRE sequences in the second intron of the mouse ABCG1 gene that were functional in HepG2 cells when tested with plasmids containing two tandem copies. These elements, termed "LXRE-6" and "LXRE-3," are orthologous to human LXRE-B and LXRE-C, respectively, in the present study. Our studies agree with Nakamura et al. regarding the robust activity of human LXRE-B/mouse LXRE-6, and extend their findings by demonstrating marked induction of the ABCG1 gene promoter by distantly placed native but not mutated LXRE-B in two physiologically relevant cell lines (Figs. 4, 5A) . We also confirm their finding that the mouse LXRE-C confers LXR responsiveness. However, we found that the human LXRE-C region is nearly devoid of activity in transfection assays (Figs. 4, 5C ) unless LXR and RXR are overexpressed (Fig. 6) . Furthermore, in EMSA experiments with nuclear extracts, a human LXRE-C probe appears to bind much less complex supershifted with anti-LXR than does the analogous mouse LXRE-C probe. (Fig.  9A) . Although the DR4 sequences of human and mouse LXRE-C are identical except for the noncritical third and fourth bases of the inter-repeat sequence, the bases surrounding the DR4 are not well conserved, particularly adjacent to the RXR binding region, where a potentially significant single-base deletion characterizes the chimp and human sequences when aligned to dog, rodent, and chicken sequences (Fig. 5D) . We conclude that LXRE-A, which has not been reported previously, and LXRE-B are the probable major LXREs regulating the ABCG1 gene of humans and probably other mammals, whereas LXRE-C, which is less highly conserved and apparently stronger in mouse than in human, may contribute to regulation of the ABCG1 gene more in subprimate species than in primates.
Undiscovered but important LXREs may exist in the introns of other genes involved in reverse cholesterol transport and lipid metabolism. For example, introns 1 and 5 of the ABCA1 genes of human, mouse, and other mammals possess conserved DR4-like sequences very similar to those of LXRE-B of the ABCG1 gene. 3 It is interesting to speculate that these elements may participate with the previously reported LXRE in the ABCA1 promoter (36, 37) to enhance or ensure LXR responsiveness. The possible existence of multiple, evolutionarily conserved, and functionally cooperative LXREs regulating both the ABCG1 and ABCA1 genes suggests that the LXR control of these genes is of great importance in the regulation of lipid and cholesterol homeostasis and for the survival of the organism.
